Next Article in Journal
Attitudes and Recommendations of Physicians towards Alcohol Consumption and Cardiovascular Health: A Perspective from Argentina
Previous Article in Journal
Central Nervous System Vasculitis for Cryptococcosis in an Immunocompetent Patient
Previous Article in Special Issue
Wine: An Aspiring Agent in Promoting Longevity and Preventing Chronic Diseases
Article Menu
Issue 3 (September) cover image

Export Article

Open AccessFeature PaperArticle
Diseases 2018, 6(3), 76; https://doi.org/10.3390/diseases6030076

Wine and Olive Oil Phenolic Compounds Interaction in Humans

1
Integrated Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM-Institut Hospital del Mar d’Investigacions Mèdiques, Dr. Aiguader 88, 08003 Barcelona, Spain
2
Department of Experimental and Health Sciences, Universitat Pompeu Fabra (CEXS-UPF), Dr. Aiguader 80, 08003 Barcelona, Spain
3
CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN, CB06/03/028), Monforte de Lemos 3-5, 28029 Madrid, Spain
*
Author to whom correspondence should be addressed.
Received: 19 July 2018 / Revised: 24 August 2018 / Accepted: 27 August 2018 / Published: 1 September 2018
(This article belongs to the Special Issue Wine and Vine Components and Health)
Full-Text   |   PDF [1603 KB, uploaded 1 September 2018]   |  

Abstract

Extra virgin olive oil (EVOO) and red wine (RW) are two basic elements that form part of the so-called Mediterranean diet. Both stand out because of their high phenolic compound content and their potential related health benefits. The present study is focused on the metabolic disposition of resveratrol (RESV), tyrosol (TYR), and hydroxytyrosol (HT) following the consumption of EVOO, RW, and a combination of both. In this study, 12 healthy volunteers consumed a single dose of 25 mL of EVOO, 150 mL of RW, and a combination of both in a crossover randomized clinical trial. Urinary recovery of RESV, TYR, and HT was analysed in urine samples collected over a 6-h period following the intake of each treatment. Higher HT levels were observed following EVOO compared to RW (3788 ± 1751 nmols and 2308 ± 847 nmols respectively). After the combination of EVOO and RW, the recovery of TYR and HT metabolites increased statistically compared to their separate consumption (4925 ± 1751 nmols of TYR and 6286 ± 3198 nmols of HT). EVOO triggered an increase in glucuronide conjugates, while RW intake raised sulfate metabolites. Marginal effects were observed in RESV increased bioavailability after the combination of RW with the fat matrix provided by EVOO. View Full-Text
Keywords: hydroxytyrosol; tyrosol; resveratrol; EVOO; olive oil; RW; red wine; Mediterranean diet hydroxytyrosol; tyrosol; resveratrol; EVOO; olive oil; RW; red wine; Mediterranean diet
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Boronat, A.; Martínez-Huélamo, M.; Cobos, A.; de la Torre, R. Wine and Olive Oil Phenolic Compounds Interaction in Humans. Diseases 2018, 6, 76.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top